FOXO4-DRI
FOXO4-DRI is a D-retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering their selective apoptosis. one of the most expensive research peptides on PeptideCompare, and one of the most scientifically interesting in longevity research.
| # | Suppliers | Price | €/mg | Price trend (6 months) | Purity | COA | Score ⓘ | |
|---|---|---|---|---|---|---|---|---|
| 1 |
PEP
PEPTIVAE
in stock NL
| €149.95 | €15/mg | 99% | — Pending | — | Shop → | |
| 2 |
LUM
LUMO PEPTIDES
in stock
| €159.95 | €15.99/mg | 99% | ✔ Bridge Labs | Shop → | ||
| 3 |
| €180 | — | 99% | ✔ HPLC | Shop → | ||
| 4 |
24P
24PEPTIDES
in stock
| €179 | €17.9/mg | ▼2.6% | 99% | ✔ Liquilabs | Shop → | |
| 5 |
CERTAPEPTIDES
in stock RO
| €185.99 | €18.6/mg | 99.3% | ✔ Janoshik | Shop → | ||
| 6 |
RES
RESEARCH PEPTIDES EUROPE
in stock ES
| €189.99 | €19/mg | 99.8% | ✔ HPLC/LC-MS | Shop → | ||
| 7 |
PU
PURECHEMS
in stock
| €199.99 | €20.0/mg | 99% | — Pending | Shop → | ||
| 8 |
PAR
PARTICLE PEPTIDES
in stock SK
| €214.99 | — | 99% | ✔ HPLC/LC-MS | Shop → |
Prices manually checked and updated monthly — source: publicly available supplier data. No affiliate links, no paid placement.
FOXO4-DRI
Mechanism, evidence level, EU status and COA guidance per compound. No dosages, no protocols — that belongs with a doctor.





